Treating Elderly Patients with Hormone Receptor–Positive Advanced Breast Cancer
As the overall population ages, the proportion of elderly patients (aged ≥65 years) with breast cancer also increases. Studies have shown that elderly patients with hormone receptor–positive breast cancer can derive as much benefit from treatment as do younger patients, yet they remain underrepresen...
Main Author: | David Riseberg |
---|---|
Format: | Article |
Language: | English |
Published: |
SAGE Publishing
2015-01-01
|
Series: | Clinical Medicine Insights: Oncology |
Online Access: | https://doi.org/10.4137/CMO.S26067 |
Similar Items
-
Treating Elderly Patients With Hormone Receptor–Positive Advanced Breast Cancer
by: David Riseberg
Published: (2015-08-01) -
Considerations for payers in managing hormone receptor-positive advanced breast cancer
by: Chitre M, et al.
Published: (2014-07-01) -
Circulating microRNAs in patients with hormone receptor-positive, metastatic breast cancer treated with dovitinib
by: Narayan Shivapurkar, et al.
Published: (2017-10-01) -
Clinical implications of recent studies using mTOR inhibitors to treat advanced hormone receptor-positive breast cancer
by: Arena F
Published: (2014-10-01) -
Glutamine Metabolism Drives Growth in Advanced Hormone Receptor Positive Breast Cancer
by: Diane M. Demas, et al.
Published: (2019-08-01)